Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Early research (Phase 1)Active Not RecruitingNCT03025256What this trial is testingIntravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseWho this might be right forAcral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)Study completedNCT00243061What this trial is testingAZD2171 in Treating Patients With Recurrent or Stage IV MelanomaWho this might be right forAcral Lentiginous Malignant MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small Size+8 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00577382What this trial is testingSU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous MelanomaWho this might be right forMucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma Dana-Farber Cancer Institute 52
Early research (Phase 1)Ended earlyNCT04653038What this trial is testingEvaluate the Safety and Efficacy of MGD013 in Patients With MelanomaWho this might be right forUnresectable, Recurrent or Metastatic MelanomaUntreated Mucosal or Acral Lentiginous Melanoma Zai Lab (Shanghai) Co., Ltd. 92
Early research (Phase 1)Study completedNCT00005057What this trial is testingGene Therapy and Ganciclovir in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) National Human Genome Research Institute (NHGRI)
Testing effectiveness (Phase 2)Study completedNCT02875132What this trial is testingPembrolizumab in Advanced/Metastatic Acral Lentiginous MelanomaWho this might be right forAcral Lentiginous Melanoma Chinese University of Hong Kong 9
Testing effectiveness (Phase 2)Looking for participantsNCT04511013What this trial is testingCompare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain MetastasesWho this might be right forAcral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more SWOG Cancer Research Network 112
Testing effectiveness (Phase 2)WithdrawnNCT02535078What this trial is testingPhase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous MelanomaWho this might be right forMalignant Melanoma Immunocore Ltd
Testing effectiveness (Phase 2)Study completedNCT00788775What this trial is testingNilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged MelanomaWho this might be right forMucosal Lentiginous MelanomaAcral MelanomaMelanoma Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06797297What this trial is testingEvaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic TherapyWho this might be right forMelanoma Innovent Biologics (Suzhou) Co. Ltd. 180
Early research (Phase 1)Looking for participantsNCT05098210What this trial is testingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more Fred Hutchinson Cancer Center 25
Testing effectiveness (Phase 2)UnknownNCT05087602What this trial is testingToripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant MelanomaWho this might be right forLocally Advanced or Metastatic Acral Malignant Melanoma Qilu Hospital of Shandong University 29
Testing effectiveness (Phase 2)Study completedNCT00881049What this trial is testingTrial of Imatinib (Gleevec®) in Selected Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma Peking University 1
Testing effectiveness (Phase 2)Study completedNCT00700882What this trial is testingDasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By SurgeryWho this might be right forMelanoma (Skin) Eastern Cooperative Oncology Group 81
Testing effectiveness (Phase 2)Looking for participantsNCT07155317What this trial is testingTime-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME TrialWho this might be right forAdvanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more Emory University 99
Early research (Phase 1)Active Not RecruitingNCT05628883What this trial is testingProof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory MelanomaWho this might be right forMetastatic MelanomaUnresectable MelanomaAcral Melanoma+7 more H. Lee Moffitt Cancer Center and Research Institute 17